Loading...
UFP Technologies Q1 2025 Earnings Report
UFP Technologies reported strong first-quarter results for 2025, with significant increases in revenue, net income, and EPS, driven by robust demand in the medical market.
Key Takeaways
UFP Technologies, Inc. announced record first-quarter results for 2025, with net income rising to $17.2 million and diluted EPS reaching $2.21. Net sales increased to $148.1 million, up from $105.0 million in the prior year, primarily due to strong growth in the MedTech business.
Net income increased 35.4% to $17.2 million in Q1 2025.
Diluted EPS rose to $2.21 in Q1 2025, up from $1.64 in Q1 2024.
Net Sales for Q1 2025 were $148.1 million, a 41.1% increase from Q1 2024.
MedTech business grew 50%, driven by strong demand in Safe Patient Handling.
Revenue by Segment
Forward Guidance
UFP Technologies anticipates continued growth, particularly in its MedTech business, supported by strategic expansions, new manufacturing agreements, and ongoing acquisition efforts. The company expects significant revenue generation from new robotic surgery programs in 2026 and beyond.
Positive Outlook
- Exclusive manufacturing rights for a significant portion of Safe Patient Handling business through June 2030.
- Doubled the size of Santiago, Dominican Republic manufacturing operation to accommodate growing demand.
- Committed to a fifth building at La Romana Robotic Surgery campus and installed new equipment lines for two robotic surgery programs.
- New robotic surgery programs scheduled to launch in the second half of the year are expected to generate significant revenue in 2026 and beyond.
- Balance sheet has strengthened as the company continues to pay down debt, and the pipeline of new opportunities is substantial and growing.
Challenges Ahead
- Robotic Surgery sales declined 6% in Q1 2025, though expected to grow modestly this year.
- Advanced Components business declined 15% as resources are focused on MedTech opportunities.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...